Patients-Reported Oral Manifestations in Coeliac Disease and Inflammatory Bowel Diseases: An Italian Survey
Abstract
:1. Introduction
2. Materials and Methods
2.1. Inclusion Criteria
2.2. Exclusion Criteria
3. Results
4. Discussion
Limitation of the Study
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Sartor, R.B. Mechanisms of Disease: Pathogenesis of Crohn’s disease and ulcerative colitis. Nat. Clin. Pract. Gastroenterol. Hepatol. 2006, 3, 390–407. [Google Scholar] [CrossRef]
- Sands, E.B. From symptom to diagnosis: Clinical distinctions among various forms of intestinal inflammation. Gastroenterology 2004, 126, 1518–1532. [Google Scholar] [CrossRef]
- Nambu, R.; Warner, N.; Mulder, D.J.; Kotlarz, D.; McGovern, D.P.; Cho, J.; Klein, C.; Snapper, S.B.; Griffiths, A.M.; Iwama, I.; et al. A Systematic Review of Monogenic Inflammatory Bowel Disease. Clin. Gastroenterol. Hepatol. 2022, 20, e653–e663. [Google Scholar] [CrossRef]
- Garber, A.; Regueiro, M. Extraintestinal Manifestations of Inflammatory Bowel Disease: Epidemiology, Etiopathogenesis, and Management. Curr. Gastroenterol. Rep. 2019, 21, 31. [Google Scholar] [CrossRef]
- Vavricka, S.R.; Rogler, G.; Gantenbein, C.; Spoerri, M.; Vavricka, M.P.; Navarini, A.A.; French, L.E.; Safroneeva, E.; Fournier, N.; Straumann, A.; et al. Chronological Order of Appearance of Extraintestinal Manifestations Relative to the Time of IBD Diagnosis in the Swiss Inflammatory Bowel Disease Cohort. Inflamm. Bowel Dis. 2015, 21, 1794–1800. [Google Scholar] [CrossRef] [PubMed]
- Katsanos, K.H.; Torres, J.; Roda, G.; Brygo, A.; Delaporte, E.; Colombel, J.-F. Review article: Non-malignant oral manifestations in inflammatory bowel diseases. Aliment. Pharmacol. Ther. 2015, 42, 40–60. [Google Scholar] [CrossRef]
- Vasovic, M.; Gajovic, N.; Brajkovic, D.; Jovanovic, M.; Zdravkovaic, N.; Kanjevac, T. The relationship between the immune system and oral manifestations of inflammatory bowel disease: A review. Central Eur. J. Immunol. 2016, 3, 302–310. [Google Scholar] [CrossRef] [PubMed]
- Triantafillidis, J.K.; Valvi, F.Z.; Merikas, E.; Peros, G.; Galitis, O.N.; Gikas, A. Granulomatous cheilitis associated with exacerbations of Crohn’s disease: A case report. J. Med. Case Rep. 2008, 2, 60. [Google Scholar] [CrossRef] [Green Version]
- Laranjeira, N.; Fonseca, J.; Meira, T.; Freitas, J.; Valido, S.; Leitão, J. Oral mucosa lesions and oral symptoms in inflammatory bowel disease patients. Arq. Gastroenterol. 2015, 52, 105–110. [Google Scholar] [CrossRef] [PubMed]
- Lankarani, K.B.; Sivandzadeh, G.R.; Hassanpour, S. Oral manifestation in inflammatory bowel disease: A review. World J. Gastroenterol. 2013, 19, 8571–8579. [Google Scholar] [CrossRef]
- Mays, J.W.; Sarmadi, M.; Moutsopoulos, N.M. Oral Manifestations of Systemic Autoimmune and Inflammatory Diseases: Diagnosis and Clinical Management. J. Evid. Based Dent. Pract. 2012, 12, 265–282. [Google Scholar] [CrossRef] [PubMed]
- Dupuy, A.; Cosnes, J.; Revuz, J.; Delchier, J.-C.; Gendre, J.P.; Cosnes, A. Oral Crohn disease: Clinical characteristics and long-term follow-up of 9 cases. Arch. Dermatol. 1999, 135, 439–442. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Zbar, A.P.; Ben-Horin, S.; Beer-Gabel, M.; Eliakim, R. Oral Crohn’s disease: Is it a separable disease from orofacial granulomatosis? A review. J. Crohn’s Colitis 2012, 6, 135–142. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lauritano, D.; Boccalari, E.; Di Stasio, D.; Della Vella, F.; Carinci, F.; Lucchese, A.; Petruzzi, M. Prevalence of Oral Lesions and Correlation with Intestinal Symptoms of Inflammatory Bowel Disease: A Systematic Review. Diagnostics 2019, 9, 77. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Litsas, G. Crohn’s disease of the mouth: Report of a case. Eur. J. Paediatr. Dent. 2011, 12, 198–200. [Google Scholar]
- Trost, L.B.; McDonnell, J.K. Important cutaneous manifestations of inflammatory bowel disease. Postgrad. Med. J. 2005, 81, 580–585. [Google Scholar] [CrossRef] [Green Version]
- Ficarra, G.; Cicchi, P.; Amorosi, A.; Piluso, S. Oral Crohn’s disease and pyostomatitis vegetans: An unusual association. Oral Surg. Oral Med. Oral Pathol. 1993, 75, 220–224. [Google Scholar] [CrossRef]
- Katz, J.; Shenkman, A.; Stavropoulos, F.; Melzer, E. Oral signs and symptoms in relation to disease activity and site of involvement in patients with inflammatory bowel disease. Oral Dis. 2003, 9, 34–40. [Google Scholar] [CrossRef]
- Grossner-Schreiber, B.; Fetter, T.; Hedderich, J.; Kocher, T.; Schreiber, S.; Jepsen, S. Prevalence of dental caries and periodontal disease in patients with inflammatory bowel disease: A case-control study. J. Clin. Periodontol. 2006, 33, 478–484. [Google Scholar] [CrossRef]
- Zervou, F.; Gikas, A.; Merikas, E.; Peros, G.; Sklavaina, M.; Loukopoulos, J.; Triantafillidis, J.K. Oral manifestations of patients with inflammatory bowel disease. Ann. Gastroenterol. 2004, 17, 395–401. [Google Scholar]
- Bernstein, C.N.; Blanchard, J.F.; Rawsthorne, P.; Yu, N. The Prevalence of Extraintestinal Diseases in Inflammatory Bowel Disease: A Population-Based Study. Am. J. Gastroenterol. 2001, 96, 1116–1122. [Google Scholar] [CrossRef] [PubMed]
- Jang, H.-J.; Kang, B.; Choe, B.-H. The difference in extraintestinal manifestations of inflammatory bowel disease for children and adults. Transl. Pediatr. 2019, 8, 4–15. [Google Scholar] [CrossRef]
- Stawarski, A.; Iwańczak, B.; Krzesiek, E.; Iwańczak, F. Powikłania jelitowe i objawy pozajelitowe w przebiegu nieswoistych zapaleń jelit u dzieci [Intestinal complications and extraintestinal manifestations in children with inflammatory bowel disease]. Pol. Merkur. Lek. 2006, 20, 22–25. (In Polish) [Google Scholar]
- Greuter, T.; Bertoldo, F.; Rechner, R.; Straumann, A.; Biedermann, L.; Zeitz, J.; Misselwitz, B.; Scharl, M.; Rogler, G.; Safroneeva, E.; et al. Extraintestinal Manifestations of Pediatric Inflammatory Bowel Disease: Prevalence, Presentation, and Anti-TNF Treatment. J. Pediatr. Gastroenterol. Nutr. 2017, 65, 200–206. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Leone, V.; Chang, E.B.; Devkota, S. Diet, microbes, and host genetics: The perfect storm in inflammatory bowel diseases. J. Gastroenterol. 2013, 48, 315–321. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Caio, G.; Volta, U.; Sapone, A.; Leffler, D.A.; De Giorgio, R.; Catassi, C.; Fasano, A. Celiac disease: A comprehensive current review. BMC Med. 2019, 17, 142. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Freeman, H.J. Application of the Vienna Classificaton for Crohn’s Disease to a Single Clinician Database of 877 Patients. Can. J. Gastroenterol. 2001, 15, 89–93. [Google Scholar] [CrossRef] [Green Version]
- Cosnes, J.; Gower–Rousseau, C.; Seksik, P.; Cortot, A. Epidemiology and Natural History of Inflammatory Bowel Diseases. Gastroenterology 2011, 140, 1785–1794.e4. [Google Scholar] [CrossRef]
- Kelsen, J.; Baldassano, R.N. Inflammatory bowel disease: The difference between children and adults. Inflamm. Bowel Dis. 2008, 14 (Suppl. 2), S9–S11. [Google Scholar] [CrossRef]
- Cushing, K.; Higgins, P.D.R. Management of Crohn Disease. JAMA 2021, 325, 69–80. [Google Scholar] [CrossRef]
- Freeman, H.J. Natural history and long-term clinical course of Crohn’s disease. World J. Gastroenterol. 2014, 20, 31–36. [Google Scholar] [CrossRef] [PubMed]
- Ludvigsson, J.F.; Leffler, D.A.; Bai, J.C.; Biagi, F.; Fasano, A.; Green, P.H.; Hadjivassiliou, M.; Kaukinen, K.; Kelly, C.P.; Leonard, J.N.; et al. The Oslo definitions for coeliac disease and related terms. Gut 2013, 6, 43–52. [Google Scholar] [CrossRef] [PubMed]
- Vivas, S.; de Morales, J.M.R.; Fernandez, M.; Hernando, M.; Herrero, B.; Casqueiro, J.; Gutierrez, S. Age-Related Clinical, Serological, and Histopathological Features of Celiac Disease. Am. J. Gastroenterol. 2008, 103, 2360–2365. [Google Scholar] [CrossRef]
- Reilly, N.R.; Aguilar, K.; Hassid, B.G.; Cheng, J.; DeFelice, A.R.; Kazlow, P.; Green, P.H. Celiac disease in normal-weight and overweight children: Clinical features and growth outcomes following a gluten-free diet. J. Pediatr. Gastroenterol. Nutr. 2011, 53, 528–531. [Google Scholar] [CrossRef]
- Volta, U.; Caio, G.; Stanghellini, V.; De Giorgio, R. The changing clinical profile of celiac disease: A 15-year experience (1998–2012) in an Italian referral center. BMC Gastroenterol. 2014, 14, 194. [Google Scholar] [CrossRef] [Green Version]
- Scully, C.; Hodgson, T. Recurrent oral ulceration: Aphthous-like ulcers in periodic syndromes. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endodontol. 2008, 106, 845–852. [Google Scholar] [CrossRef] [PubMed]
- Oviedo, C.; Yañez, M.; Pennacchiotti, V. Frequency of Oral Manifestation in Patients with Inflammatory Bowel Disease in Chile. Int. J. Odontostomatol. 2017, 11, 267–271. [Google Scholar] [CrossRef] [Green Version]
- Muhvić-Urek, M.; Tomac-Stojmenović, M.; Mijandrušić-Sinčić, B. Oral pathology in inflammatory bowel disease. World J. Gastroenterol. 2016, 22, 5655–5667. [Google Scholar] [CrossRef]
- Bens, G.; Laharie, D.; Beylot-Barry, M.; Vergier, B.; Noblesse, I.; Beylot, C.; Amouretti, M. Successful treatment with infliximab and methotrexate of pyostomatitis vegetans associated with Crohn’s disease. Br. J. Dermatol. 2003, 149, 181–184. [Google Scholar] [CrossRef]
- Van Assche, G.; Dignass, A.; Panes, J.; Beaugerie, L.; Karagiannis, J.; Allez, M.; Ochsenkühn, T.; Orchard, T.; Rogler, G.; Louis, E.; et al. The second European evidence-based Consensus on the diagnosis and management of Crohn’s disease: Definitions and diagnosis. J. Crohn’s Colitis 2010, 4, 7–27. [Google Scholar] [CrossRef] [Green Version]
Specific Lesions | Description | CD * | UC ** |
---|---|---|---|
Cobblestoning mucosa | Hyperplastic, fissured, and swollen mucosa with corrugation | YES | NO |
Mucosal tags | Indurated tag-like lesions, with hyperplastic edges, boggy, or firm to palpation | YES | NO |
Non-caseous granulomatous lesions | Granulomas (core of activated macrophages) surrounded by fibrotic tissue and lymphocytes | YES | NO |
Mucogingivitis | Edematous, granular, and hyperplastic gingiva | YES | NO |
Non-Specific Lesions | Description | CD * | UC ** |
---|---|---|---|
Aphthous stomatitis | Shallow round ulcerations with central fibrine membrane, surrounded by an erythematous halo | YES | YES |
Angular cheilitis | Erythema with/without painful fissures and sores at mouth corners | YES | YES |
Pyostomatitis vegetans | Small exophytic lesions with erythematous border and creamy surface with erosions | NO | YES |
Glossitis | Swollen and inflamed tongue | YES | YES |
Questions | Options |
---|---|
Do you suffer from one of these diseases? | Crohn’s Disease (CD) Ulcerative Colitis (UC) Coeliac Disease (CoD) Irritable Bowel Syndrome (IBS) |
When did you discover your disease? | In early childhood (0–6 years old) In childhood (7–12 years old) In adolescence (13–19 years old) In adulthood (over 20 years old) |
How did you discover your disease? | Weight loss Abdominal pain Blood or mucus in the stool Constipation or diarrhea |
If you have noticed oral mucosa inflammation (pain, vesicles, burning) during acute phases, please describe it. | No options |
Q1: Do You Suffer from One of These Diseases? | ||
---|---|---|
Crohn’s Disease (CD) | 8 | 18.18% |
Ulcerative Colitis (UC) | 8 | 18.18% |
Coeliac Disease (Cod) | 20 | 45.46% |
Irritable Bowel Syndrome (IBS) | 8 | 18.18% |
Q2: When did you discover your disease? | ||
In early childhood (0–6 yo) | 4 | 8.89% |
In childhood (7–12 yo) | 4 | 8.89% |
In adolescence (13–19 yo) | 8 | 17.78% |
In adulthood (over 20 yo) | 29 | 64.44% |
Q3: How did you discover your disease? | ||
Weight loss | 10 | 22.22% |
Abdominal pain | 13 | 28.89% |
Blood/mucus in the stool | 7 | 15.56% |
Diarrhea/constipation | 15 | 33.33% |
Q4: If you have noticed oral mucosa inflammation (pain, vesicles, burning …) during acute phases, please describe it. | ||
No | 9 | 31.03% |
I don’t know | 1 | 3.45% |
Yes | 19 | 65.52% |
| 12 | 63.16% |
| 1 | 5.26% |
| 5 | 26.32% |
| 1 | 5.26% |
| 2 | 10.52% |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Valentini, G.; D’Agostino, S.; Ferrara, E.; Dolci, M. Patients-Reported Oral Manifestations in Coeliac Disease and Inflammatory Bowel Diseases: An Italian Survey. Oral 2023, 3, 316-324. https://doi.org/10.3390/oral3030026
Valentini G, D’Agostino S, Ferrara E, Dolci M. Patients-Reported Oral Manifestations in Coeliac Disease and Inflammatory Bowel Diseases: An Italian Survey. Oral. 2023; 3(3):316-324. https://doi.org/10.3390/oral3030026
Chicago/Turabian StyleValentini, Giulia, Silvia D’Agostino, Elisabetta Ferrara, and Marco Dolci. 2023. "Patients-Reported Oral Manifestations in Coeliac Disease and Inflammatory Bowel Diseases: An Italian Survey" Oral 3, no. 3: 316-324. https://doi.org/10.3390/oral3030026